bioRxivImmunologyPreprint
Neural Network-Assisted Humanization of COVID-19 Hamster scRNAseq Data Reveals Matching Severity States in Human Disease
V. D. Friedrich, P. Pennitz, E. Wyler, J. M. Adler, D. Postmus, L. G. T. Alves, J. Prigann, F. Pott, D. Vladimirova, T. Hoefler, C. Goekeri, M. Landthaler, C. Goffinet, A.-E. Saliba, M. Scholz, M. Witzenrath, J. Trimpert, H. Kirsten, G. Nouailles
Abstract
Translating findings from animal models to human disease is essential for dissecting disease mechanisms, developing and testing precise therapeutic strategies. The coronavirus disease 2019 (COVID-19) pandemic has highlighted this need, particularly for models showing disease severity-dependent immune responses. Single-cell transcriptomics (scRNAseq) is well poised to reveal similarities and differences between species at the molecular and cellular level with unprecedented resolution. However, computational methods enabling detailed matching are still scarce. Here, we provide a structured scRNAseq-based approach that we applied to scRNAseq from blood leukocytes originating from humans and hamsters affected with moderate or severe COVID-19. Integration of COVID-19 patient data with two hamster models that develop moderate (Syrian hamster, Mesocricetus auratus) or severe (Roborovski hamster, Phodopus roborovskii) disease revealed that most cellular states are shared across species. A neural network-based analysis using variational autoencoders quantified the overall transcriptomic similarity across species and severity levels, showing highest similarity between neutrophils of Roborovski hamsters and severe COVID-19 patients, while Syrian hamsters better matched patients with moderate disease, particularly in classical monocytes. We further used transcriptome-wide differential expression analysis to identify which disease stages and cell types display strongest transcriptional changes. Consistently, hamsters response to COVID-19 was most similar to humans in monocytes and neutrophils. Disease-linked pathways found in all species specifically related to interferon response or inhibition of viral replication. Analysis of candidate genes and signatures supported the results. Our structured neural network-supported workflow could be applied to other diseases, allowing better identification of suitable animal models with similar pathomechanisms across species. Key PointsO_LINeural networks can successfully match disease states between animal models and humans using single-cell data as shown for COVID-19 C_LIO_LIModerately diseased patients best matched Syrian hamster cells; severely diseased patients best matched Roborovski hamster neutrophils C_LI
- organism: human
- organism: mouse
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: deep learning
- approach: variational autoencoder
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-cell-resolved interspecies comparison identifies a shared inflammatory axis and a dominant neutrophil-endothelial program in severe COVID-19
S. Peidli, G. Nouailles, … S. D. Praktiknjo·bioRxiv·Aug 25, 2023
- Longitudinal omics in Syrian hamsters integrated with human data unravel complexity of moderate immune responses to SARS-CoV-2
G. Nouailles, E. Wyler, … M. Witzenrath·bioRxiv·Dec 18, 2020
- Host response of Syrian hamster to SARS-CoV-2 infection, including differences with humans and between sexes
M. Castellan, G. Zamperin, … S. Leopardi·bioRxiv·Nov 22, 2022
- Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model
K. L. O'Donnell, A. N. Pinski, … A. Marzi·bioRxiv·Jul 11, 2021
- AImmune: a new blood-based machine learning approach to improving immune profiling analysis on COVID-19 patients
Runpeng Harris Han, Xi Tom Zhang·medRxiv·Nov 26, 2021
- ScRNA-Seq study of neutrophils reveals vast heterogeneity and breadth of inflammatory responses in severe COVID-19 patients
J. Xu, B. He, … J. A. Deng·bioRxiv·Dec 1, 2021